FDA Expands Emergency Use for Pfizer’s COVID-19 Vaccine for Children

Video Credit: Wibbitz Top Stories
Published on May 11, 2021 - Duration: 00:54s

FDA Expands Emergency Use for Pfizer’s COVID-19 Vaccine for Children

FDA Expands Emergency Use for Pfizer’s COVID-19 Vaccine for Children.

Pfizer’s COVID-19 vaccine for children aged 12 to 15 has received emergency use authorization in the United States.

.

An analysis of 1,005 participants in the age group found the vaccine to be 100 percent effective at preventing COVID-19.

.

Pfizer’s vaccine is still the only one to be approved so far for children aged 16 to 18.

.

According to FDA acting commissioner Janet Woodcock, adolescents will receive the same dosage and regimen as adults.

.

This will allow for vaccine distribution sites to simply “extend down to the younger age group” and provide access to millions of adolescents.

Today's action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic, Janet Woodcock, via CBS News


You are here

Related news from verified sources

An advisory panel of the Centres for Disease Control and Prevention recommended the use of the Pfizer-BioNTech COVID-19 vaccine for children aged between 12 and...
on May 13, 2021 • Zee News

The World Health Organisation has given the go-ahead for emergency use of Moderna's COVID-19 vaccine. The mRNA vaccine from the US manufacturer joins vaccines...
on May 1, 2021 • IndiaTimes

Related videos from verified sources

Masked Concerns for Young Children Too Young for Vaccinations 01:12
Video credit: Veuer - Published on May 27, 2021 

The White House and Snapchat Together in Pursuit of Reaching Young Vaccine Hesitant 01:33
Video credit: Veuer - Published on May 26, 2021 

Moderna Says Its COVID-19 Vaccine Is Safe and Effective in 12- to 17-Year-Olds 01:02
Video credit: Wibbitz Top Stories - Published on May 25, 2021 

You might like